Full Press Release Details
Tactile Medical Announces New Appointments to
Appoints Valerie Asbury and Brent Shafer
MINNEAPOLIS-January 5, 2022 (GLOBE NEWSWIRE)
- Tactile Systems Technology, Inc. ("Tactile Medical") (Nasdaq: TCMD), a medical technology company focused on developing
medical devices for the treatment of patients with underserved chronic diseases at home, today announced the appointment of Valerie L.
Asbury and D. Brent Shafer to the Company's Board of Directors ("Board"), effective January 5, 2022. Ms. Asbury will
serve as a member of both the Audit Committee and the Compliance & Reimbursement Committee. Mr. Shafer will serve as a member of the
Audit Committee, the Compensation & Organization Committee, and the Nominating & Corporate Governance Committee. Three long-standing
directors will be retiring from the Board ahead of the May shareholder meeting: Peter Soderberg, Richard Nigon and Kevin Roche.
"We are extremely pleased to welcome Valerie
and Brent to our Board; both experienced leaders, adding depth of expertise in the treatment of chronically ill patients and channels
to access and support them," said Bill Burke, Chairman of the Board of Tactile Medical. "I would also like to extend my sincere
gratitude to Peter, Dick and Kevin for their dedicated years of service. Their counsel and oversight played an important role in helping
Tactile Medical become a successful company, eclipsing $200 million in annual revenue."
Since 2018, Valerie Asbury has served as the President
and CEO of LifeScan, a global leader in blood glucose monitoring, serving more than 20 million people with diabetes. Ms. Asbury previously
held a series of leadership roles within Johnson & Johnson (NYSE: JNJ) for over 20 years from 1998 to 2018, including executive sales
and general management positions. Her most recent position at Johnson & Johnson was Global President of Diabetes Solutions from 2013
to 2018, including the Global LifeScan subsidiary until its sale in October 2018 to Platinum Equity, a leading private investment firm.
She holds a Bachelor of Science in Nursing from Vanderbilt University.
Brent Shafer most recently served as Chairman
and CEO of Cerner Corporation from 2018 until September 2021, a global healthcare technology company that was acquired by Oracle Corporation
(NYSE: ORCL) in December 2021. Prior to Cerner, Mr. Shafer was Chief Executive Officer of Philips North America, a health technology company
and the North American division of Koninklijke Philips N.V. ("Philips"; NYSE: PHG, AEX: PHIA), from 2014 to 2018. Mr. Shafer
also served as Chief Executive Officer of the global Philips' Home Healthcare Solutions business from 2010 until 2014. Mr. Shafer previously
held a series of leadership roles at Philips, Hill Rom and GE Healthcare. He holds a Bachelor of Science from the University of Utah.
About Tactile Medical
Tactile Medical is a leader in developing
and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous
insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. The company collaborates
with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the
quality of life for tens of thousands of patients each year.